Jesy Nelson has questioned Health Secretary Wes Streeting about the delay in addressing her case involving a severe muscle wasting disease before it became a pressing issue. The former Little Mix member met with Mr. Streeting to advocate for the implementation of newborn screening for spinal muscular atrophy (SMA), a condition her twin babies have been diagnosed with, impacting their ability to walk.
The Mirror is campaigning for the inclusion of a simple £5 SMA check in the NHS newborn heel prick test, aiming to enable early detection and treatment to prevent irreversible nerve damage in infants, a practice already adopted in many developed countries.
During a filmed meeting on ITV’s This Morning, Jesy expressed her frustration at the lack of attention to SMA screening, questioning why it took her intervention to raise awareness. Mr. Streeting acknowledged the valid concerns raised by Jesy and other affected families, emphasizing the significance of early diagnosis in improving outcomes.
Joined by SMA UK representatives, Jesy highlighted the urgent need for early screening to avoid the devastating impact of delayed diagnoses, an issue affecting many families across the UK. The charity emphasized the availability of life-changing treatments for SMA and the potential to transform outcomes for affected children.
Novartis, a pharmaceutical company, estimated that around 33 UK infants annually suffer from delayed diagnoses of SMA, leading to mobility challenges. Despite recent advancements in SMA treatments, the UK National Screening Committee has postponed the nationwide implementation of SMA screening until at least 2031, citing the need for further research.
While England awaits the outcome of a screening pilot, Scotland has decided to proceed with SMA screening as part of routine newborn testing, emphasizing the importance of early detection and intervention. Mr. Streeting reassured Jesy and SMA UK of ongoing evaluations to support the expansion of SMA screening across the UK.
Novartis UK’s Chief Medical Officer expressed support for Jesy’s advocacy efforts and urged the government to align with European standards by implementing universal SMA screening. The company highlighted Zolgensma, a gene therapy offering a potential cure if administered promptly after birth, underscoring the critical window for effective treatment.
Jesy’s personal account of her twins’ SMA diagnosis underscored the emotional toll of delayed interventions, emphasizing the rapid progression of the condition and the missed opportunities for early treatment. Her plea for improved screening resonated with healthcare professionals and advocates, emphasizing the need for timely action to prevent unnecessary suffering.
The article also mentioned Jesy’s recent separation from her fiancé, Zion Foster, who is the father of her twins, Ocean Jade and Story Monroe.